Combinations with a backbone-cyclized peptide
A novel combination comprising a β-hairpin peptidomimetic of the formula cyclo(-Thr-Trp-Ile-Dab-Orn- D Dab-Dab-Trp-Dab-Dab-Ala-Ser- D Pro-Pro) (I), and a compound of the glycylcycline class, especially tigecycline, that enable therapeutic control of specific bacterial infections in human or animals at doses of the individual compounds lower than either of the compounds administered alone. The combination can be used as a medicament to treat e.g. skin or soft tissue infections; eye, ear, blood stream, or intra-abdominal infections; infections related to respiratory diseases, to bone diseases, to cardiovascular diseases, to genitourinal diseases, or to gastrointestinal diseases.
1. A combination comprising:
a β-hairpin peptidomimetic of the formula cyclo(-Thr-Trp-Ile-Dab-Orn-DDab-Dab-Trp-Dab-Dab-Ala-Ser-DPro-Pro) (I), wherein Dab is (S)-2,4-diaminobutanoic acid, DDab is (R)-2,4-diaminobutanoic acid, and Orn is (S)-2,5-diaminopentanoic acid; and
a compound of the glycylcycline class,
or pharmaceutically acceptable salts.
2. A combination according to claim 1 wherein the compound of the glycylcycline class is tigecycline or a pharmaceutically acceptable salt thereof.
3. A pharmaceutical composition comprising a combination according to claim 1 and at least one pharmaceutically inert carrier.
4. A pharmaceutical composition according to claim 3 in a form suitable for oral, topical, transdermal, injection, infusion, buccal, transmucosal, rectal, vaginal, pulmonary or inhalation administration, especially in the form of tablets, dragees, capsules, solutions, liquids, gels, plaster, creams, ointments, syrup, slurries, powders, suspensions, spray, nebulizer or suppositories.
5. A kit comprising a part containing a β-hairpin peptidomimetic of the formula (I) according to claim 1 , or a pharmaceutically acceptable salt thereof and a part containing a compound of the glycylcycline class or a pharmaceutically acceptable salt thereof.
6. A kit according to claim 5 wherein the compound of the glycylcycline class is tigecycline or a pharmaceutically acceptable salt thereof.
7. A method of treating a bacterial infection or disease related to such infection in human or animals comprising administering to a subject in need thereof an adequate amount of a combination according to claim 1 .
8. A method of treating a bacterial infection or disease related to such infection in human or animals comprising a kit according to claim 5 .
9. A method of manufacturing a pharmaceutical composition comprising the step of combining the combination according to claim 1 with at least one pharmaceutically inert carrier.
10. A method of treating a bacterial infection or disease related to such infection in human or animals comprising administering to a subject in need thereof a therapeutically acceptable amount of a pharmaceutical composition according to claim 3 .